学术报告:The Advantage of Sensitivity and Precision in Genetic, Expression and Epigenetic Studies

- Applications of DNA Mass Spectrometry in Cancer and Other Human Diseases

主讲人：Dr. Charles Cantor
Member of the National Academy of Sciences（美国科学院院士）.

主持人：曾益新院士

时间：2007年8月20日 （星期一）上午 10:00 时

地点：肿瘤防治中心23楼远程会议中心

Summary
In this special seminar, Dr. Charles Cantor will share with his audience data from some very significant DNA studies that he and his colleagues performed exclusively on a Mass Spectrometry system. His presentation will include whole genome SNP association studies of cancer and other important human diseases, DNA re-sequencing, SNP discovery and validation, mutation detection and screening, DNA methylation studies, gene expression profiling and quantification, DNA biomarker trace analysis and prenatal molecular diagnostics.

Bio of Dr. Cantor

Dr. Charles Cantor is a founder, Chief Scientific Officer, and Member, Board of Directors, at SEQUENOM, Inc.  He is also founder of SelectX Pharmaceuticals, a drug discovery company based in the Boston area. He is co-director of the Center for Advanced Biotechnology at Boston University, and professor of Biomedical Engineering.  Dr. Cantor has held positions at Columbia University and University of California at Berkeley, and was also director of the Human Genome Center of the Department of Energy at Lawrence Berkeley Laboratory.  He has published more than 400 peer-reviewed articles, has been granted more than 60 patents, and co-authored a three-volume textbook on Biophysical Chemistry and the first textbook on Genomics:  The Science and Technology of the Human Genome Project.  He sits on the advisory boards of more than 20 national and international organizations and is a member of the National Academy of Sciences.

欢迎参加！